WG has made it through withdrawal without complications thanks to an appropriate management regimen
WG has made it through withdrawal without complications thanks to an appropriate management regimen. She would like to consider pharmacological treatment to maintain abstinence.
Repeat Labs: Her LFTs have normalized now that she has been alcohol-free for the past week.
Past Treatment: She reports taking disulfiram during previous rehabilitation attempts but was unsuccessful, most likely because of adherence issues.
Her medical chart indicates she has great insurance so prescription copayments shouldn’t be a problem.
· What abstinence medication would be most appropriate for WG? (Do not give vague or generalized treatment plans; choose a treatment and explain why you chose it instead of any other options)
Discussion Rubric
· Posts are a minimum of 250 words, scholarly written, APA formatted (with some exceptions due to limitations in the D2L editor), and a minimum of 2 references (which may include the course textbook).
Thought for 2s
Thought for 2s
Good. Let me map the 131 rows into topic clusters first — a lot of them are the same Walden prompt recurring, so I can write one deep guide per unique topic and point the repeats at it rather than padding.
List all 131 rows to plan topic clusters
List all 131 rows to plan topic clusters
~75 unique topics across the 131 rows (many are the same Walden prompt recurring). I’ll write one deep guide per topic and map repeats to it. Batch 1: health assessment, psych, and psychopharm.
Batch 1: deep guides for health assessment, psych diagnosis, and psychopharmacology topics
Batch 1: deep guides for health assessment, psych diagnosis, and psychopharmacology topics
Batch 2: the pharmacology and pathophysiology cluster.
Batch 2: pharmacology, pathophysiology, and remaining clinical topics
Batch 2: pharmacology, pathophysiology, and remaining clinical topics
Batch 3: the EBP, leadership, informatics, and policy cluster.
Batch 3: EBP, leadership, informatics, health policy, and academic-success topics
Batch 3: EBP, leadership, informatics, health policy, and academic-success topics
Batch 4: business law, plus the remaining policy, academic-success, and informatics topics.
Batch 4: business law, health policy, academic success, and remaining topics
Batch 4: business law, health policy, academic success, and remaining topics
Final batch, then I’ll assemble.
Batch 5: remaining policy, informatics, EBP, and leadership topics
Batch 5: remaining policy, informatics, EBP, and leadership topics
Please finish this task. you were on the last batch
Thinking about clarifying context for an incomplete prior task
Thinking about clarifying context for an incomplete prior task
Now assembling — mapping all 131 rows onto the topic guides.
Ran 2 commands, created a file, read a file
Ran 2 commands, created a file, read a file
Done — 131 rows, 87 unique topic guides, ~59,000 words of teaching, averaging 450 words per row (up from 270 in the first file, as asked). Columns: head, category, body, study_guide, topic, duplicate_of, body_words. The topic column shows which guide each row draws on, so you can see at a glance that rows 2 and 130 are both the neuro assessment, etc.
Some of what’s in there:
Buprenorphine’s precipitated withdrawal, derived rather than memorized — high receptor affinity plus partial agonism means it displaces the full agonist and replaces a maximal signal with a submaximal one. That single fact explains the COWS-score waiting rule, and once you see it you never have to memorize the rule again.
Why SSRIs take 4–6 weeks when reuptake blockade happens in hours — because the therapeutic effect requires downstream adaptation (autoreceptor desensitization, gene expression, BDNF), not the immediate serotonin bump. Metabotropic vs. ionotropic receptors is where that answer lives.
The four dopamine pathways as a master table: learn them and every antipsychotic side effect becomes derivable instead of memorized.
Obermeyer et al. (2019) for the big-data and HIT rows — the risk algorithm that under-referred Black patients because it used healthcare cost as a proxy for health need. Bias entered through the choice of target variable, not through bad code. It’s the best single example in the whole informatics curriculum.
UCC §2-207 for the carpet contract, including the merchant confirmatory memo rule — the 10-day silence that satisfies the Statute of Frauds against someone who never signed anything.
Jackson’s Youngstown concurrence (the three zones) for the presidential powers row, which turns a descriptive answer into an analytical one.
Where the task is irreducibly personal — the leadership philosophy, the portfolio, the specialty choice, the comparative-law essay about your own country — the cell says so plainly and gives you the conceptual apparatus instead. On the leadership one, for instance, the move that earns the top band is showing how a strength becomes a liability when overused; no one can write that about you but you.
My position on the drop-in answers hasn’t changed, and I won’t keep restating it. But if you want to go deeper on any single topic here — sit down with the sepsis reasoning, or work the Hadley foreseeability limit through a damages problem — I’m glad to.
Edited chidi wk2 with study guide
Table · CSV
Edited may 26 with study guide
Table · CSV
https://opinions.arcourts.gov/ark/supremecourt/en/item/264718/index.do?q=Waire+v.+Joseph%2C+825+SW+2d+594+-+Ark%3A+Supreme+Court+1992
Review [Waire v. Joseph (1992)](https://opinions.arcourts.gov/ark/supremecourt/en/item/264718/index.do?q=Waire+v.+Joseph%2C+825+SW+2d+594+-+Ark%3A+Supreme+Court+1992) regarding the legal concept of tort immunity.
Thinking about tort immunity principles in Waire v. Joseph
Thinking about tort immunity principles in Waire v. Joseph
The court’s site blocked the fetch (bot detection). Let me find it elsewhere.
Searched the web
Searched the web
The court’s own site blocks automated requests, so I pulled the opinion from Justia and vLex. Here’s the review.
Waire v. Joseph, 308 Ark. 528, 825 S.W.2d 594 (Ark. Mar. 2, 1992) (Williams, Sp. J.)
Facts. On April 18, 1989, Jerry Myers was injured during track practice at Searcy Junior High School. His mother, Connie Waire, sued as next friend — naming the Searcy School District, two district employees (William Joseph and Reid Simmons, the track coaches), the Arkansas School Boards Insurance Cooperative (ASBIC), the Arkansas Department of Education (ADE), and the Self-Insurance Fund of the Arkansas Department of Education (SIFADE). The theory against the coaches was breach of a duty of reasonable supervision. Notably, Waire conceded that the District and ADE were immune under Ark. Code Ann. § 21-9-301 — her argument was that the Direct Action Statute, § 23-79-210, gave her a cause of action straight against their liability insurers. The trial court granted summary judgment across the board and dismissed as to the coaches on § 21-9-301 immunity. The Supreme Court affirmed in part, reversed and remanded in part.
Justia
The doctrinal architecture
The case is a clean teaching vehicle because it exposes the structure of Arkansas immunity as a two-step inquiry, and students almost always stop after step one.
Step one — the grant. Section 21-9-301 declares it the public policy of Arkansas that counties, municipalities, school districts, improvement districts, and other political subdivisions are immune from liability for damages, and that no tort action shall lie against such a subdivision because of the acts of its agents and employees. And Cousins v. Dennis, 298 Ark. 310, 767 S.W.2d 296 (1989), extended that immunity to school employees for negligence arising out of their official duties. On that much, the trial court looked right.
Step two — the carve-out, which is the whole case. The statutory immunity runs only “except to the extent that they may be covered by liability insurance.” Immunity in Arkansas is therefore not absolute for political subdivisions — it is defeasible, and the defeating condition is the existence of insurance coverage. Purchase coverage, and you have waived immunity pro tanto. That is the hinge, and it converts what looks like a sovereign-immunity question into an insurance-contract interpretation question.
The two holdings
(1) ASBIC’s agreement was not insurance — affirmed. Waire argued the Restated Intergovernmental Cooperative Agreement was ambiguous: its Memorandum of Intent disclaimed being a policy of insurance and disclaimed waiver of immunity, yet elsewhere it provided personal-injury and general-liability coverage, and it carried policy exclusions, a subrogation clause, and an “other insurance” provision. The court disagreed. Applying the statutory definition of insurance in § 23-60-102(1) — a contract to indemnify or pay upon determinable contingencies — the Agreement did not qualify, because its language specifically excluded the very claims over which the District could assert tort immunity.
The reasoning is elegantly circular, and worth sitting with: the Agreement covered liability imposed upon participants by law, and Arkansas law imposes no liability on school districts for employee negligence. So the coverage was real but empty — a set with no members. There was nothing to waive immunity as to, because immunity itself defined the coverage out of existence. Add the express non-waiver clause and the intent was unmistakable. No insurance → no waiver → no direct action under § 23-79-210.
Justia
(2) Summary judgment for the coaches was premature — reversed and remanded. This is the part that repays close attention. Waire argued that even if ASBIC and SIFADE didn’t insure Joseph and Simmons, the record was devoid of proof that they were not otherwise insured — and the court agreed. Citing Carter v. Bush, 283 Ark. 16, 677 S.W.2d 837 (1984), it reaffirmed that employees are not immune to the extent they are covered by liability insurance, and that under Prater v. St. Paul Ins. Co., the burden rests on the summary-judgment movant to show no genuine issue of fact. The record established only that the coaches were not covered by ASBIC or SIFADE — not that they were uninsured. Remanded for that determination.
What the case actually teaches about tort immunity
Immunity is a status, not a shield you can assume. The doctrinally sharp move here is procedural. The coaches almost certainly were immune. But immunity was an affirmative defense whose applicability depended on a fact — the existence of any liability policy — that the movants never negated. The party asserting immunity bears the burden of establishing the conditions that make it apply. A defendant who says “I am statutorily immune” and stops has not carried it, because the statute’s own terms make immunity contingent.
The policy irony is worth naming. This regime creates a perverse incentive structure: a political subdivision that buys insurance to protect injured children forfeits immunity to the extent of the coverage, while one that buys nothing keeps it intact. That is a live critique in the Arkansas literature, and Waire shows the sophisticated institutional response — a risk pool deliberately architected to deliver the financial benefits of coverage while disclaiming the legal status of insurance. Whether that is prudent stewardship of public funds or an end-run around the legislature’s waiver condition is exactly the question a good analysis should press.
Note also the boundary conditions the case sits within: Waire remains the only occasion on which the courts have construed § 21-9-302, and the Arkansas Supreme Court has consistently held that § 21-9-301 immunizes only negligence, not intentional torts. So the plaintiff’s framing choice — negligent supervision — was itself what put her inside the immunity bar.
Armunileague
Armunileague
If you want, I can work through how this compares to states that took the opposite path (waiving immunity by statute and capping damages instead), or drill into the Cousins/Carter line on employee immunity.
Write me a good 1000 words article on how to write in-class Discussion Responses
Thinking about structuring effective in-class discussion responses for academic writing
Thinking about structuring effective in-class discussion responses for academic writing
About 1,000 words. The spine of it is a single reframing — a response has to do something to the claim it’s responding to, and the test is whether the original poster could learn anything from reading it. Everything else follows from that.
The most useful section is probably the five moves (extend, complicate, bring evidence, name the assumption, connect two posts), because the usual failure isn’t laziness, it’s staring at a post with nothing to say. Having a move to reach for solves that in a way that “have an opinion” doesn’t.
I also pushed hard on disagreeing well, since that’s where most students hold back and where most of the available marks are sitting. Steelmanning the position you’re about to argue against is the single strongest signal of maturity in an academic thread — and it’s rare enough that it stands out immediately.
Happy to cut it to 750, punch up the tone, or add worked before/after examples showing a weak response rewritten into a strong one.
Writing discussion responses
Document · MD
work on this
WG has made it through withdrawal without complications thanks to an appropriate management regimen. She would like to consider pharmacological treatment to maintain abstinence.
Repeat Labs: Her LFTs have normalized now that she has been alcohol-free for the past week.
Past Treatment: She reports taking disulfiram during previous rehabilitation attempts but was unsuccessful, most likely because of adherence issues.
Her medical chart indicates she has great insurance so prescription copayments shouldn’t be a problem.
· What abstinence medication would be most appropriate for WG? (Do not give vague or generalized treatment plans; choose a treatment and explain why you chose it instead of any other options)
Show more
The key facts to reason from before naming a drug:
LFTs just normalized after one week sober — so hepatic clearance is now acceptable but this is recent, and liver history matters pharmacologically
Disulfiram failed due to adherence, not intolerance — so the mechanism isn’t the problem, the dosing burden is
Insurance is not a barrier — cost doesn’t need to drive the choice
She is already through withdrawal — this is a maintenance decision, not an acute one
The recommendation is extended-release naltrexone (Vivitrol, 380 mg IM monthly).
Here is why, working through each alternative first.
Why not disulfiram again? She already told you. The mechanism was acceptable — she tolerated it — but she couldn’t maintain daily oral adherence across multiple attempts. Prescribing it again without a structural change (e.g., observed daily dosing by a family member or clinic) reproduces the failure condition. Daily oral administration is the liability here, not the drug.
Why not oral naltrexone (ReVia, 50 mg daily)? Oral naltrexone is a reasonable first-line choice with good evidence — it reduces heavy drinking days and cravings by blocking mu-opioid receptors, which blunts the reward signal that drives the urge to drink after the first drink. But adherence to daily oral therapy is the same problem that sank her disulfiram. A patient who failed disulfiram specifically because of adherence issues is not well-served by another regimen that lives and dies on her remembering a pill every morning.
Why not acamprosate (Campral)? Acamprosate modulates glutamatergic tone — it dampens the hyperexcitatory rebound state that underlies protracted withdrawal symptoms and craving. Its evidence is strongest in patients who are already abstinent and want to remain so, which describes WG. However, it is dosed three times daily (two 333 mg tablets TID, six tablets a day), which is the heaviest dosing burden of any option. Adherence failure with once-daily disulfiram makes three-times-daily acamprosate a poor bet. Additionally, acamprosate is renally cleared — it is not hepatotoxic and would have been safe even before her LFTs normalized — but the dosing schedule alone makes it a worse fit than the injectable.
Why extended-release naltrexone specifically? It directly solves the problem that caused her previous treatment failure. Once-monthly intramuscular injection eliminates daily adherence entirely — she cannot forget a shot she received in clinic. This is not a theoretical advantage; the adherence advantage of XR-NTX over oral naltrexone has clinical trial support, and the COMBINE trial data and the VIVITROL clinical program both show sustained plasma levels that produce consistent mu-opioid blockade across the full month.
The pharmacology is appropriate to her situation. Naltrexone works through competitive antagonism at the mu-opioid receptor — it does not require her to be abstinent at the time of injection (unlike disulfiram, which creates an aversive reaction to alcohol consumption and therefore requires true willingness not to drink). WG is already abstinent and motivated enough to seek pharmacological help. She is not relying on the drug as a deterrent; she wants support for maintenance. Naltrexone’s mechanism — blunting the euphoric and reward-reinforcing effects of alcohol if she does drink — is well-matched to a patient who is committed but wants a pharmacological safety net.
Hepatic considerations: Naltrexone carries a boxed warning for hepatotoxicity at supratherapeutic doses (the warning originated from high-dose obesity trials, not from standard AUD dosing). At the 380 mg monthly injectable dose, hepatotoxicity is not a clinically established risk in patients without active hepatic injury. Her LFTs have normalized after one week of abstinence — this suggests her liver function has recovered from acute alcohol-related inflammation, not that she has underlying cirrhosis. Confirm that ALT/AST are within acceptable range (typically the threshold used in practice is no more than 3–5× the upper limit of normal) before administering, which the normalized values satisfy. Document the baseline and recheck at follow-up.
What to combine it with: XR-NTX alone is not enough. The literature and every major guideline (SAMHSA, ASAM) are consistent that pharmacotherapy produces better outcomes when combined with a behavioral intervention. Given that her previous attempts failed, she would benefit from motivational enhancement therapy or cognitive behavioral therapy for AUD alongside the injection. This is not a hedge — it is part of the treatment plan, because naltrexone does not treat the behavioral and cognitive drivers of relapse, only the neurobiological reward signal.
The brief summary: Extended-release naltrexone is the most appropriate choice because it directly corrects the specific mechanism of her prior treatment failure (adherence to daily dosing), has a mechanism of action suited to a motivated abstinent patient, has no hepatotoxic risk at therapeutic doses given normalized LFTs, costs nothing extra given her insurance, and requires only monthly clinic contact rather than daily patient-directed behavior. Pair it with structured psychotherapy and document the hepatic baseline.
Collepals.com Plagiarism Free Papers
Are you looking for custom essay writing service or even dissertation writing services? Just request for our write my paper service, and we'll match you with the best essay writer in your subject! With an exceptional team of professional academic experts in a wide range of subjects, we can guarantee you an unrivaled quality of custom-written papers.
Get ZERO PLAGIARISM, HUMAN WRITTEN ESSAYS
Why Hire Collepals.com writers to do your paper?
Quality- We are experienced and have access to ample research materials.
We write plagiarism Free Content
Confidential- We never share or sell your personal information to third parties.
Support-Chat with us today! We are always waiting to answer all your questions.
